Article info
Acid inhibitory therapy
Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies
- Correspondence to Prof. Changhua Zhang, Center for Digestive Disease, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China; zhchangh{at}mail.sysu.edu.cn; Prof. Yulong He, Center for Digestive Disease, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China; heyulong{at}mail.sysu.edu.cn
Citation
Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies
Publication history
- Received July 16, 2020
- Revised August 6, 2020
- Accepted August 9, 2020
- First published September 28, 2020.
Online issue publication
January 08, 2022
Article Versions
- Previous version (7 May 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.